Four months of rifampicin for tuberculosis prevention treatment in children

J Infect Chemother. 2023 Feb;29(2):235. doi: 10.1016/j.jiac.2022.10.016. Epub 2022 Nov 9.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibiotics, Antitubercular* / therapeutic use
  • Antitubercular Agents / therapeutic use
  • Child
  • Humans
  • Mycobacterium tuberculosis*
  • Rifampin / therapeutic use
  • Tuberculosis* / drug therapy
  • Tuberculosis* / prevention & control
  • Tuberculosis, Pulmonary* / drug therapy
  • Tuberculosis, Pulmonary* / prevention & control

Substances

  • Rifampin
  • Antitubercular Agents
  • Antibiotics, Antitubercular